Back

Restoration of Gamma Center Frequency via Personalized Entrainment Marks Cognitive Preservation in Early Alzheimer's Disease

Park, Y.; Chae, H.; Yoon, E.; Kim, Y.; Han, J. W.; Woo, S. J.; Yoo, S.; Kim, K. W.

2026-01-28 psychiatry and clinical psychology
10.64898/2026.01.23.26344352
Show abstract

BackgroundGamma entrainment shows promise for Alzheimers disease (AD) treatment in preclinical models, but human trials have yielded heterogeneous results. We hypothesized that the clinical efficacy of gamma entrainment depends on individual neurophysiological receptivity, specifically the capacity for neural circuit plasticity. MethodsIn this open-label pilot study, we screened 37 individuals and enrolled 16 participants with early AD (CDR 0.5-1.0, amyloid-positive) who completed 12 weeks of home-based flickering light stimulation at individually optimized gamma frequencies (32-40 Hz). Pre- and post-intervention assessments included 64-channel EEG recordings and MMSE. ResultsParticipants demonstrated dichotomous neurophysiological responses: 43.8% showed CF increase (ICF+) while 56.3% showed no change/decrease (ICF-). CF restoration was significantly associated with cognitive preservation (r=0.52, p=0.039). Notably, future responders exhibited distinct baseline signatures of "neural reserve," characterized by higher temporal gamma power (Cohens d=0.70-0.92) and stronger frontotemporal connectivity (Cohens d=1.11-1.47). Almost 30% of screened candidates failed to show baseline entrainment, highlighting a distinct "non-responsive" biological subtype. DiscussionCF restoration following personalized gamma entrainment identifies a neurophysiological subtype capable of meaningful plasticity. Rather than a universal remedy, gamma entrainment appears to act on specific neural substrates preserved in a subset of patients. These findings suggest that baseline electrophysiological profiling could unlock gamma entrainments therapeutic potential by stratifying likely responders for precision neuromodulation.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Molecular Psychiatry
based on 84 papers
Top 0.5%
10.0%
2
Nature Communications
based on 483 papers
Top 9%
8.2%
3
Brain
based on 69 papers
Top 2%
7.5%
4
NeuroImage: Clinical
based on 77 papers
Top 2%
7.5%
5
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
based on 28 papers
Top 0.7%
6.3%
6
Alzheimer's & Dementia: Translational Research & Clinical Interventions
based on 13 papers
Top 0.1%
5.2%
7
Translational Psychiatry
based on 94 papers
Top 3%
5.0%
8
Alzheimer's & Dementia
based on 84 papers
Top 3%
4.6%
50% of probability mass above
9
Alzheimer's Research & Therapy
based on 31 papers
Top 2%
2.8%
10
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
based on 27 papers
Top 1%
2.8%
11
Brain Communications
based on 79 papers
Top 4%
2.4%
12
Journal of Neurology, Neurosurgery & Psychiatry
based on 26 papers
Top 2%
2.4%
13
NeuroImage
based on 36 papers
Top 2%
2.2%
14
Human Brain Mapping
based on 53 papers
Top 4%
1.7%
15
Biological Psychiatry Global Open Science
based on 23 papers
Top 2%
1.6%
16
eLife
based on 262 papers
Top 18%
1.6%
17
Proceedings of the National Academy of Sciences
based on 100 papers
Top 10%
1.3%
18
Brain, Behavior, and Immunity
based on 35 papers
Top 2%
1.3%
19
Journal of Alzheimer’s Disease
based on 23 papers
Top 3%
1.3%
20
Nature Medicine
based on 88 papers
Top 11%
1.3%
21
Neuropsychopharmacology
based on 29 papers
Top 3%
1.2%
22
Frontiers in Neurology
based on 74 papers
Top 10%
1.2%
23
Scientific Reports
based on 701 papers
Top 84%
0.8%
24
Psychological Medicine
based on 52 papers
Top 6%
0.8%
25
Biological Psychiatry
based on 36 papers
Top 4%
0.8%
26
Science Advances
based on 52 papers
Top 7%
0.7%
27
Science
based on 46 papers
Top 8%
0.7%
28
Neurobiology of Aging
based on 29 papers
Top 4%
0.7%
29
Nature Genetics
based on 72 papers
Top 9%
0.7%
30
npj Digital Medicine
based on 85 papers
Top 15%
0.7%